These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 1918715)

  • 1. Cardiac abnormalities in the toxic oil syndrome, with comparative observations on the eosinophilia-myalgia syndrome.
    James TN; Gómez-Sánchez MA; Martínez-Tello FJ; Posada-de la Paz M; Abaitua-Borda I; Soldevilla LB
    J Am Coll Cardiol; 1991 Nov; 18(5):1367-79. PubMed ID: 1918715
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histologic abnormalities of large and small coronary arteries, neural structures, and the conduction system of the heart found in postmortem studies of individuals dying from the toxic oil syndrome.
    James TN; Posada-de la Paz M; Abaitua-Borda I; Gomez-Sanchez MA; Martinez-Tello FJ; Soldevilla LB
    Am Heart J; 1991 Mar; 121(3 Pt 1):803-15. PubMed ID: 2000747
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunohistochemical analysis of lymphocytes in postmortem study of the heart from fatal cases of the eosinophilia myalgia syndrome and of the toxic oil syndrome.
    Hayashi T; James TN
    Am Heart J; 1994 May; 127(5):1298-308. PubMed ID: 8172059
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Postmortem studies of the heart in three fatal cases of the eosinophilia-myalgia syndrome.
    James TN; Kamb ML; Sandberg GA; Silver RM; Kilbourne EM
    Ann Intern Med; 1991 Jul; 115(2):102-10. PubMed ID: 2058857
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The toxic oil syndrome.
    James TN
    Clin Cardiol; 1994 Sep; 17(9):463-70. PubMed ID: 8001309
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Bolster MB; Silver RM
    Curr Opin Rheumatol; 1994 Nov; 6(6):642-9. PubMed ID: 7865387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Abnormalities of the coronary arteries, neural structures and conduction system of the heart observed postmortem in the eosinophilia-myalgia syndrome, with a discussion of comparative findings from the toxic oil syndrome.
    James TN
    Trans Am Clin Climatol Assoc; 1991; 102():52-81; discussion 81-3. PubMed ID: 2130570
    [No Abstract]   [Full Text] [Related]  

  • 8. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Silver RM
    Curr Opin Rheumatol; 1993 Nov; 5(6):802-8. PubMed ID: 8117543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The eosinophilia-myalgia syndrome and the toxic oil syndrome. Pursuing parallels.
    Hertzman PA
    Adv Exp Med Biol; 1996; 398():339-42. PubMed ID: 8906286
    [No Abstract]   [Full Text] [Related]  

  • 10. Pulmonary hypertension in patients with eosinophilia-myalgia syndrome or toxic oil syndrome.
    Cheng TO
    Mayo Clin Proc; 1993 Aug; 68(8):823-4. PubMed ID: 8331987
    [No Abstract]   [Full Text] [Related]  

  • 11. 3-(Phenylamino)alanine--a link between eosinophilia-myalgia syndrome and toxic oil syndrome?
    Philen RM; Hill RH
    Mayo Clin Proc; 1993 Feb; 68(2):197-200. PubMed ID: 8423703
    [No Abstract]   [Full Text] [Related]  

  • 12. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Silver RM
    Curr Opin Rheumatol; 1992 Dec; 4(6):851-6. PubMed ID: 1457280
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The toxic oil syndrome and the eosinophilia-myalgia syndrome: pursuing clinical parallels.
    Hertzman PA; Borda IA
    J Rheumatol; 1993 Oct; 20(10):1707-10. PubMed ID: 8295182
    [No Abstract]   [Full Text] [Related]  

  • 14. Toxic oil syndrome. A long-term follow-up of a cohort of 332 patients.
    Alonso-Ruiz A; Calabozo M; Perez-Ruiz F; Mancebo L
    Medicine (Baltimore); 1993 Sep; 72(5):285-95. PubMed ID: 8412642
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome.
    Kilbourne EM; Posada de la Paz M; Abaitua Borda I; Diez Ruiz-Navarro M; Philen RM; Falk H
    J Am Coll Cardiol; 1991 Sep; 18(3):711-7. PubMed ID: 1869734
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 3-(Phenylamino)alanine, a novel aniline-derived amino acid associated with the eosinophilia-myalgia syndrome: a link to the toxic oil syndrome?
    Mayeno AN; Belongia EA; Lin F; Lundy SK; Gleich GJ
    Mayo Clin Proc; 1992 Dec; 67(12):1134-9. PubMed ID: 1469924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Toxic oil syndrome and eosinophilia-myalgia syndrome: May 8-10, 1991, World Health Organization meeting report.
    Philen RM; Posada M
    Semin Arthritis Rheum; 1993 Oct; 23(2):104-24. PubMed ID: 8266108
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Eosinophilia myalgia syndrome (EMS) caused by L-tryptophan product and toxic oil syndrome (TOS) caused by denatured rape-seed oil].
    Maitani T; Saitoh H
    Shokuhin Eiseigaku Zasshi; 2009 Dec; 50(6):279-91. PubMed ID: 20065617
    [No Abstract]   [Full Text] [Related]  

  • 19. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
    Kaufman LD; Krupp LB
    Curr Opin Rheumatol; 1995 Nov; 7(6):560-7. PubMed ID: 8579979
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fibrogenic growth factors in the eosinophilia-myalgia syndrome and the toxic oil syndrome.
    Kaufman LD; Gruber BL; Gomez-Reino JJ; Miller F
    Arch Dermatol; 1994 Jan; 130(1):41-7. PubMed ID: 8285738
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.